BARRY RICHARD 1562371 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-23 | 2023-08-21 | 2023-08-21 to 2023-08-22 | 4 | Barry Richard | DIRECTOR | acq | 18477.0 | 6.3 | 4.4 | 16.67 | By Trust | Common Stock | CASSAVA SCIENCES INC | code P | 293477.0 | 41.97 (SAVA) |
2023-11-06 | 2023-11-03 | 4 | Barry Richard | DIRECTOR | holding | 2929842.0 | 0 | 313.2 | 0.0 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | NA | 93.55 (SRPT) | ||
2023-11-06 | 2023-11-03 | 2023-11-03 | 4 | Barry Richard | DIRECTOR | acq | 10000.0 | 100.0 | 1.07 | 78.81 | By Llc | Common Stock | SAREPTA THERAPEUTICS, INC. | code P | 10000.0 | 93.55 (SRPT) |
2023-11-06 | 2023-11-03 | 2023-11-03 | 4 | Barry Richard | DIRECTOR | acq | 40000.0 | 28.57 | 4.28 | 78.81 | By Trust | Common Stock | SAREPTA THERAPEUTICS, INC. | code P | 140000.0 | 93.55 (SRPT) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Barry Richard | DIRECTOR | acq | 1846.0 | 0.06 | 0.2 | 0.0 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code A | 2931688.0 | 93.55 (SRPT) |
2024-03-05 | 2024-03-01 | 4 | Barry Richard | DIRECTOR | holding | 10000.0 | 0 | 1.07 | 0.0 | By Llc | Common Stock | SAREPTA THERAPEUTICS, INC. | NA | 93.55 (SRPT) | ||
2024-03-05 | 2024-03-01 | 4 | Barry Richard | DIRECTOR | holding | 240000.0 | 0 | 25.66 | 0.0 | By Trust | Common Stock | SAREPTA THERAPEUTICS, INC. | NA | 93.55 (SRPT) | ||
2024-04-25 | 2024-04-23 | 2024-04-23 | 4 | Barry Richard | DIRECTOR | acq | 176085.0 | 37.5 | 40.74 | 22.0 | By Trust | Common Stock | CASSAVA SCIENCES INC | code M | 469562.0 | 43.23 (SAVA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-08 | 2023-05-04 | 2023-05-04 | 4 | Barry Richard | DIRECTOR | acq | 25000.0 | 100 | 5.99 | 22.34 | Direct | Stock Option (Right To Buy) | CASSAVA SCIENCES INC | code A | 5000.0 | 41.75 (SAVA) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Barry Richard | DIRECTOR | acq | 3679.0 | 100.0 | 0.39 | 128.67 | Direct | Stock Option (Right To Buy) | SAREPTA THERAPEUTICS, INC. | code A | 3679.0 | 93.55 (SRPT) |
2024-04-25 | 2024-04-23 | 2024-01-03 | 4 | Barry Richard | DIRECTOR | acq | 117390.0 | 66.67 | 27.16 | 33.0 | By Trust | Common Stock Warrant | CASSAVA SCIENCES INC | code A | 176085.0 | 43.23 (SAVA) |
2024-04-25 | 2024-04-23 | 2024-04-23 | 4 | Barry Richard | DIRECTOR | dsp | 117390.0 | 100.0 | 27.16 | 33.0 | By Trust | Common Stock Warrant | CASSAVA SCIENCES INC | code M | 0.0 | 43.23 (SAVA) |
2024-05-13 | 2024-05-09 | 2024-05-09 | 4 | Barry Richard | DIRECTOR | acq | 15000.0 | 100.0 | 3.13 | 21.11 | Direct | Stock Option (Right To Buy) | CASSAVA SCIENCES INC | code A | 15000.0 | 47.98 (SAVA) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)